title: Cure of Helicobacter pylori infection in all compliant patients:  report on 644 subjects.
authors.forename: Kari
authors.initials: K
authors.lastname: Seppälä
authors.forename: Timo U
authors.initials: TU
authors.lastname: Kosunen
authors.forename: Lea
authors.initials: L
authors.lastname: Veijola
authors.forename: Pentti
authors.initials: P
authors.lastname: Sipponen
authors.forename: Perttu E T
authors.initials: PE
authors.lastname: Arkkila
authors.forename: Hilpi
authors.initials: H
authors.lastname: Rautelin
authors.forename: Reijo
authors.initials: R
authors.lastname: Tilvis
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage; D015331:Cohort Studies; D024881:Drug Resistance, Bacterial; D004359:Drug Therapy, Combination; D005260:Female; D005387:Finland / Q000453:epidemiology; D005500:Follow-Up Studies; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage; D008826:Microbial Sensitivity Tests; D010349:Patient Compliance; D012189:Retrospective Studies; D018570:Risk Assessment; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D017291:Clarithromycin